| # | Drug | Count |
|---|---|---|
| 0 | BEVACIZUMAB | 33 |
| 1 | OXALIPLATIN | 25 |
| 2 | FLUOROURACIL | 23 |
| 3 | FLUOROURACIL CREAM, 0.5% | 23 |
| 4 | CAPECITABINE | 20 |
| 5 | ADALIMUMAB | 15 |
| 6 | ADALIMUMAB-AATY | 7 |
| 7 | ADALIMUMAB-ADAZ | 7 |
| 8 | ADALIMUMAB-FKJP | 7 |
| 9 | AZATHIOPRINE | 5 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | NICARDIPINE HYDROCHLORIDE | 2 | 0.0009 |
| 1 | ACETAMINOPHEN AND CODEINE PHOSPHATE | 1 | 0.0005 |
| 2 | NICARDIPINE | 2 | 0.0005 |
| 3 | AZATHIOPRINE SODIUM | 1 | 0.0004 |
| 4 | OXALIPLATIN | 25 | 0.0003 |
| 5 | LEVOLEUCOVORIN INJECTION | 1 | 0.0003 |
| 6 | FLUOROURACIL CREAM, 0.5% | 23 | 0.0003 |
| 7 | FLUOROURACIL | 23 | 0.0003 |
| 8 | BEVACIZUMAB | 33 | 0.0003 |
| 9 | LEVOLEUCOVORIN | 1 | 0.0003 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 35 | 0.0002 |
| 1 | Nucleoside Metabolic Inhibitor [EPC] | 37 | 0.0001 |
| 2 | Vitamin K [EPC] | 1 | 0.0001 |
| 3 | Platinum-based Drug [EPC] | 29 | 0.0001 |
| 4 | Programmed Death Ligand-1 Blocker [EPC] | 2 | 0.0001 |
| 5 | GLP-2 Analog [EPC] | 1 | 0.0001 |
| 6 | Epidermal Growth Factor Receptor Antagonist [EPC] | 3 | 0.0001 |
| 7 | Interleukin-23 Antagonist [EPC] | 6 | 0.0001 |
| 8 | Purine Antimetabolite [EPC] | 5 | 0.0001 |
| 9 | Interleukin-12 Antagonist [EPC] | 5 | 0.0000 |